∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
---|---|---|---|---|
INTLI - Finanziamenti internazionali |
Study of the Biological Role of LSD1/KDM1A Splicing Variants in Human Embryonic Stem Cells and Early Development
|
|
Ongoing | 2020 |
PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2021)
|
|
Ongoing | 2022 |
PRIN2020 - PRIN bando 2020 |
Multimodal Innovative THeranostic nanoSystem
|
|
Ongoing | 2022 |
FON_NAZ - Bandi Altre Fondazioni |
Metastasis AS Mechanodisease - 4° anno
|
|
Ongoing | 2022 |
FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (3° anno)
|
|
Ongoing | 2023 |
INTLI - Finanziamenti internazionali |
GM1-oligosaccharide as a new drug candidate for Rett syndrome
|
|
Ongoing | 2021 |
FON_NAZ - Bandi Altre Fondazioni |
Functional study on a new pharmacological approach in the Rett Syndrome
|
|
Ongoing | 2023 |
ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Fluoxetine reveres cognitive defects in a mouse model of AT: a preclinical study to elucidate the precise mechanism of action
|
|
Ongoing | 2022 |
FON_NAZ - Bandi Altre Fondazioni |
Evidence-based approach to treat hyperexcitability in Rett syndrome though splicing modulation
|
|
Ongoing | 2021 |
MIS - Bandi Ministero Salute |
Enhancement of the current hematopoietic stem cell-based gene therapy to broaden its accessibility to symptomatic patients affected by Metachromatic Leukodystrophy
|
|
Ongoing | 2021 |